iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
7.42
+0.20 (2.77%)
At close: Dec 20, 2024, 4:00 PM
7.45
+0.03 (0.41%)
After-hours: Dec 20, 2024, 7:29 PM EST
iTeos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 123.74 | 251.18 | 284.8 | 848.54 | 336.33 | 19.87 | Upgrade
|
| Short-Term Investments | 364.97 | 280.74 | 328.36 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 488.71 | 531.92 | 613.16 | 848.54 | 336.33 | 19.87 | Upgrade
|
| Cash Growth | -18.42% | -13.25% | -27.74% | 152.30% | 1592.80% | -9.64% | Upgrade
|
| Other Receivables | 7.8 | 6.5 | 2.44 | 12.09 | 0.33 | 5.33 | Upgrade
|
| Receivables | 42.8 | 6.5 | 2.44 | 12.09 | 0.33 | 5.33 | Upgrade
|
| Prepaid Expenses | 13.36 | 12.24 | 12.7 | 14.09 | 2.89 | 0.88 | Upgrade
|
| Total Current Assets | 544.88 | 550.65 | 628.3 | 874.71 | 339.54 | 26.08 | Upgrade
|
| Property, Plant & Equipment | 10.89 | 10.73 | 6.77 | 7.4 | 1.35 | 1.34 | Upgrade
|
| Long-Term Investments | 160.2 | 100.54 | 118.23 | - | - | - | Upgrade
|
| Other Long-Term Assets | 7.12 | 5.67 | 1.7 | 2.6 | 3.66 | 3.33 | Upgrade
|
| Total Assets | 723.08 | 667.59 | 754.99 | 884.71 | 344.56 | 30.74 | Upgrade
|
| Accounts Payable | 7.15 | 11.29 | 7.66 | 5.15 | 3.03 | 1.17 | Upgrade
|
| Accrued Expenses | 26.86 | 15.62 | 19.73 | 17.16 | 7.49 | 4.26 | Upgrade
|
| Current Portion of Leases | 1.35 | 1.25 | 0.84 | 0.77 | - | - | Upgrade
|
| Current Unearned Revenue | 1.45 | 2.06 | 13.78 | 281.05 | 4.49 | 2.36 | Upgrade
|
| Other Current Liabilities | - | 9.79 | - | - | - | 5.4 | Upgrade
|
| Total Current Liabilities | 36.81 | 40.01 | 42 | 304.12 | 15 | 13.2 | Upgrade
|
| Long-Term Leases | 4.17 | 4.81 | 3.84 | 4.57 | - | - | Upgrade
|
| Other Long-Term Liabilities | 50.4 | 47.54 | 45.82 | 23.2 | 6.36 | 1.88 | Upgrade
|
| Total Liabilities | 91.39 | 92.36 | 91.66 | 331.89 | 21.36 | 15.08 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0 | Upgrade
|
| Additional Paid-In Capital | 608.69 | 463.8 | 435.67 | 413.18 | 396.44 | - | Upgrade
|
| Retained Earnings | 33.93 | 124.63 | 237.28 | 140.62 | -73.9 | -35.87 | Upgrade
|
| Comprehensive Income & Other | -10.97 | -13.24 | -9.64 | -1.02 | 0.62 | -0.22 | Upgrade
|
| Total Common Equity | 631.69 | 575.23 | 663.33 | 552.82 | 323.2 | -36.09 | Upgrade
|
| Shareholders' Equity | 631.69 | 575.23 | 663.33 | 552.82 | 323.2 | 15.67 | Upgrade
|
| Total Liabilities & Equity | 723.08 | 667.59 | 754.99 | 884.71 | 344.56 | 30.74 | Upgrade
|
| Total Debt | 5.53 | 6.06 | 4.67 | 5.34 | - | - | Upgrade
|
| Net Cash (Debt) | 483.18 | 525.86 | 608.49 | 843.2 | 336.33 | 19.87 | Upgrade
|
| Net Cash Growth | -18.53% | -13.58% | -27.84% | 150.71% | 1592.80% | -9.64% | Upgrade
|
| Net Cash Per Share | 12.51 | 14.70 | 16.11 | 22.32 | 22.30 | 97.97 | Upgrade
|
| Filing Date Shares Outstanding | 36.53 | 35.84 | 35.72 | 35.51 | 35.1 | 0.26 | Upgrade
|
| Total Common Shares Outstanding | 36.53 | 35.84 | 35.61 | 35.47 | 35.04 | 0.26 | Upgrade
|
| Working Capital | 508.06 | 510.64 | 586.3 | 570.59 | 324.55 | 12.88 | Upgrade
|
| Book Value Per Share | 17.29 | 16.05 | 18.63 | 15.59 | 9.22 | -140.67 | Upgrade
|
| Tangible Book Value | 631.69 | 575.23 | 663.33 | 552.82 | 323.2 | -36.09 | Upgrade
|
| Tangible Book Value Per Share | 17.29 | 16.05 | 18.63 | 15.59 | 9.22 | -140.67 | Upgrade
|
| Machinery | 5.98 | 4.9 | 4.34 | 3.97 | 3.16 | 2.65 | Upgrade
|
| Leasehold Improvements | 4.35 | 4.18 | 1.24 | 1.07 | 0.86 | 0.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.